Corvionis
Cross-system execution partner for early clinical development in advanced therapies
Our core positioning
Corvionis is a Germany-based life science strategy and execution partner focused on advanced therapies, early clinical development, and high-complexity translational medicine programs.
Our core mission is to build executable development pathways across science, regulation, clinical development, and commercialization, while resolving the structural gaps that commonly arise between countries, systems, and stakeholders.
These gaps often occur between:
- Scientific research and clinical development
- Regulatory pathways and real-world execution
- Different regulatory systems across Europe, the United States, China, and other regions
- Hospitals, CROs, and industry collaboration networks
- Investment decisions and development realities
We view these structural disconnects, rather than science itself, as one of the main reasons why promising life science programs fail to progress.
Our focus areas
Advanced therapies
Complex therapeutic modalities requiring integrated regulatory, clinical, and execution planning.
Cell & gene therapy
High-complexity programs where translational, manufacturing, clinical, and regulatory systems must be aligned early.
Regenerative medicine
Development programs requiring deep translational and early clinical execution capabilities.
Oncology & precision medicine
Programs where clinical feasibility, biomarker strategy, and development pathway design are critical.
Translational medicine
Bridging scientific research, clinical relevance, and development execution.
Early clinical development
IND, FIH, Phase I readiness, and early clinical value inflection points.